T1	Participants 73 108	advanced pancreatic cancer patients
T2	Participants 298 344	patients with advanced pancreatic cancer (APC)
T3	Participants 358 489	39 patients with APC, without thrombosis, receiving chemotherapy, were entered in a randomized controlled trial (ISRCTN = 76464767)
